Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing

被引:0
|
作者
Qiubing Chen [1 ,2 ]
Xuebin Wang [1 ,2 ]
Yizhou Zhang [1 ,2 ]
Ming Tian [1 ,2 ]
Junyi Duan [1 ,2 ]
Ying Zhang [1 ,3 ]
Hao Yin [1 ,2 ,4 ,5 ]
机构
[1] Departments of Urology and Laboratory Medicine,Frontier Science Center for Immunology and Metabolism, Medical Research Institute,Zhongnan Hospital of Wuhan University,Wuhan University
[2] State Key Laboratory of Virology,Tai Kang Center for Life and Medical Sciences, Tai Kang Medical School,Wuhan University
[3] Department of Rheumatology and Immunology,Zhongnan Hospital of Wuhan University,Wuhan University
[4] Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences
[5] RNA Institute,Wuhan
关键词
D O I
暂无
中图分类号
Q78 [基因工程(遗传工程)]; TB383.1 [];
学科分类号
071007 ; 0836 ; 090102 ;
摘要
Lipid nanoparticles(LNPs) have gained clinical approval as carriers for both siRNA and mRNA. Among the crucial components of LNPs, ionizable lipids play a pivotal role in determining the efficiency of RNA delivery. In this study, we synthesized a series of ionizable lipids, denoted as HTO, with a higher count of hydroxyl groups compared to SM-102. Remarkably, LNPs based on HTO12 lipid demonstrated comparable mRNA delivery efficiency and biosafety to those based on SM-102. However, the former reduced the ratio of ionizable lipid/total lipids to mRNA in LNPs by 2.5 times compared to SM-102. The HTO12 LNP efficiently encapsulated adenine base editor mRNA and sgRNA targeting Pcsk9, leading to substantial gene editing within the liver of mice and effective reduction of the target protein. Our study underscores that ionizable lipids with multiple hydroxyl groups may facilitate an improved lipid-to-mRNA ratio to minimize the dosage of ionizable lipids for in vivo delivery.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 50 条
  • [41] Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation
    Atsavapranee, Ella
    Haley, Rebecca M.
    Billingsley, Margaret M.
    Chan, Alexander
    Ruan, Biao
    Figueroa-Espada, Christian G.
    Gong, Ningqiang
    Mukalel, Alvin J.
    Bryan, Philip N.
    Mitchell, Michael J.
    JOURNAL OF CONTROLLED RELEASE, 2024, 370 : 614 - 625
  • [42] Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function
    Ramezanpour, M.
    Schmidt, M. L.
    Bodnariuc, I.
    Kulkarni, J. A.
    Leung, S. S. W.
    Cullis, P. R.
    Thewalt, J. L.
    Tieleman, D. P.
    NANOSCALE, 2019, 11 (30) : 14141 - 14146
  • [43] Ionizable lipid nanoparticles are effective at penetrating the core of epithelial ovarian cancer spheroids
    Tal, O.
    Levy, T.
    Ramishetti, S.
    Milo, D. Landesman
    Peer, D.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 83 - 83
  • [44] An ionizable lipid toolbox for RNA delivery
    Han, Xuexiang
    Zhang, Hanwen
    Butowska, Kamila
    Swingle, Kelsey L.
    Alameh, Mohamad-Gabriel
    Weissman, Drew
    Mitchell, Michael J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [45] An ionizable lipid toolbox for RNA delivery
    Xuexiang Han
    Hanwen Zhang
    Kamila Butowska
    Kelsey L. Swingle
    Mohamad-Gabriel Alameh
    Drew Weissman
    Michael J. Mitchell
    Nature Communications, 12
  • [46] Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
    Luo, Ying-Li
    Xu, Cong-Fei
    Li, Hong-Jun
    Cao, Zhi-Ting
    Liu, Jing
    Wang, Ji-Long
    Du, Xiao-Jiao
    Yang, Xian-Zhu
    Gu, Zhen
    Wang, Jun
    ACS NANO, 2018, 12 (02) : 994 - 1005
  • [47] In silico prediction of siRNA ionizable-lipid nanoparticles In vivo efficacy: Machine learning modeling based on formulation and molecular descriptors
    Metwally, Abdelkader A.
    Nayel, Amira A.
    Hathout, Rania M.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [48] In vivo protein corona patterns of lipid nanoparticles
    Amici, A.
    Caracciolo, G.
    Digiacomo, L.
    Gambini, V.
    Marchini, C.
    Tilio, M.
    Capriotti, A. L.
    Colapicchioni, V.
    Matassa, R.
    Familiari, G.
    Palchetti, S.
    Pozzi, D.
    Mahmoudi, M.
    Lagana, A.
    RSC ADVANCES, 2017, 7 (02): : 1137 - 1145
  • [49] In vivo fate of lipid-based nanoparticles
    Qi, Jianping
    Zhuang, Jie
    Lu, Yi
    Dong, Xiaochun
    Zhao, Weili
    Wu, Wei
    DRUG DISCOVERY TODAY, 2017, 22 (01) : 166 - 172
  • [50] Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
    Chadwick, Alexandra C.
    Evitt, Niklaus H.
    Lv, Wenjian
    Musunuru, Kiran
    CIRCULATION, 2018, 137 (09) : 975 - 977